Finance

Lists
ECL:NYSE
Ecolab Inc
300,68 USD
-1,68%
(-5,15) 1D
300,68 USD
0,00% (0,00)
After hours
Closed: 6-ноя., 16:02:25 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECL...
Open
300,00 USD
High
304,14 USD
Low
297,00 USD
Mkt. cap
84,33 млд
Avg. vol.
1,49 млн
Volume
2,22 млн
Dividend
0,97%
Quarterly dividend
0,73 USD
Ex-dividend date
2026-ж., 15-сен.
P/E ratio
40,89
52-wk high
318,93 USD
52-wk low
243,15 USD
EPS
7,35 USD
Beta
0,85
Shares outstanding
280,47 млн
No. of employees
48 миң
Open
300,00 USD
High
304,14 USD
Low
297,00 USD
Mkt. cap
84,33 млд
Avg. vol.
1,49 млн
Volume
2,22 млн
Dividend
0,97%
Quarterly dividend
0,73 USD
Ex-dividend date
2026-ж., 15-сен.
P/E ratio
40,89
52-wk high
318,93 USD
52-wk low
243,15 USD
EPS
7,35 USD
Beta
0,85
Shares outstanding
280,47 млн
No. of employees
48 миң
News stories
From web sources and news partners
Profile
Ecolab Inc., headquartered in Saint Paul, Minnesota, provides products related to water treatment, sanitation, and hygiene, primarily to commercial and industrial customers. The company is ranked 274th on the Fortune 500 and 569th on the Forbes Global 2000. Wikipedia
About Ecolab Inc
CEOChristophe Beck
Employees48 миң
Founded1923
HeadquartersСейнт Пол, Миннесота, Америка Кошмо Штаттары
SectorMaterials
IndustrySpeciality chemicals
Websiteecolab.com
Analyst ratings
Based on 12 analysts giving stock ratings to ECL in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ECL in the last 3 months.
Highest
Current 300,68 USD
360,00 USD (+19,73%)
Average
329,64 USD (+9,63%)
Lowest
295,00 USD (-1,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
John McNulty
BMO Capital
Buy
Maintained
360,00 USD
+19,7%
10/27/2026
Scott Schneeberger
Oppenheimer
Buy
Maintained
320,00 USD
+6,4%
10/28/2026
Joshua Spector
UBS
Buy
Reiterated
357,00 USD
+18,7%
10/28/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Reiterated
310,00 USD
+3,1%
10/28/2026
Andrew Wittmann
Robert W. Baird
Buy
Maintained
317,00 USD
+5,4%
10/28/2026
Patrick Cunningham
Citi
Buy
Maintained
345,00 USD
+14,7%
10/28/2026
Vincent Andrews
Morgan Stanley
Buy
Maintained
330,00 USD
+9,8%
10/27/2026
Matthew DeYoe
Bank of America Securities
Buy
Reiterated
355,00 USD
+18,1%
10/28/2026
Ashish Sabadra
RBC Capital
Buy
Maintained
337,00 USD
+12,1%
10/28/2026
Manav Patnaik
Barclays
Buy
Maintained
300,00 USD
-0,2%
10/28/2026
Tim Mulrooney
William Blair
Buy
Maintained
-
-
09/28/2026
Jason Haas CFA
Wells Fargo
Hold
Reiterated
295,00 USD
-1,9%
09/16/2026
John Eade
Argus Research
Buy
Maintained
310,00 USD
+3,1%
08/04/2026
Jim Kelleher
Argus Research
Buy
Maintained
310,00 USD
+3,1%
08/04/2026
Unknown Analyst
Raymond James
Hold
Maintained
-
-
07/31/2026
Shlomo Rosenbaum
Stifel Nicolaus
Buy
Reiterated
337,00 USD
+12,1%
07/29/2026
John Roberts CFA
Mizuho Securities
Buy
Maintained
327,00 USD
+8,8%
07/28/2026
David Begleiter
Deutsche Bank
Buy
Maintained
335,00 USD
+11,4%
07/09/2026
Laurence Alexander
Jefferies
Buy
Maintained
345,00 USD
+14,7%
05/20/2026
Eric Boyes
Evercore ISI
Buy
Maintained
312,00 USD
+3,8%
04/29/2026
Andres Castanos-Mollor
Berenberg Bank
Buy
Maintained
321,00 USD
+6,8%
03/27/2026
Chris Parkinson
Wolfe Research
Hold
Maintained
-
-
03/20/2026
Michael Harrison CFA
Seaport Global
Buy
Maintained
340,00 USD
+13,1%
02/12/2026
Last report
2026-ж., 27-окт.
Fiscal period
Q3 2026
2,18 USD / 2,17 USD
+0,30%beat
Revenue / Est. (USD)
4,69 млд / 4,70 млд
-0,11%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
13,44%
10,64%
12,11%
11,74%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору